Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 3374119)

Published in Eur J Epidemiol on March 27, 2012

Authors

Lili Ma1, Ling Oei, Lindi Jiang, Karol Estrada, Huiyong Chen, Zhen Wang, Qiang Yu, Maria Carola Zillikens, Xin Gao, Fernando Rivadeneira

Author Affiliations

1: Department of Rheumatology, Fudan University, Shanghai, China.

Articles citing this

The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56

Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus & occurrence of osteoporosis. Indian J Med Res (2015) 2.08

The Generation R Study: Biobank update 2015. Eur J Epidemiol (2014) 1.26

High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care (2013) 1.19

Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int (2014) 0.98

Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep (2015) 0.88

Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women. J Bone Miner Metab (2013) 0.87

Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type 2 Diabetes. J Clin Diagn Res (2015) 0.87

Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol (Lausanne) (2013) 0.85

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. J Clin Endocrinol Metab (2016) 0.84

Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int (2015) 0.83

Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties. Bone (2015) 0.83

Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus. Indian J Endocrinol Metab (2014) 0.82

Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study. Osteoporos Int (2013) 0.82

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients. Osteoporos Int (2013) 0.82

The Association between Metabolic Syndrome, Bone Mineral Density, Hip Bone Geometry and Fracture Risk: The Rotterdam Study. PLoS One (2015) 0.81

Development and Validation of Osteoporosis Risk-Assessment Model for Korean Men. Yonsei Med J (2016) 0.81

Association Between Insulin Resistance and Bone Structure in Nondiabetic Postmenopausal Women. J Clin Endocrinol Metab (2016) 0.80

Wrist breadth and homeostasis model assessment of insulin resistance in youth: the Fels Longitudinal Study. Am J Hum Biol (2013) 0.80

High glucose inhibits receptor activator of nuclear factor‑κB ligand-induced osteoclast differentiation via downregulation of v‑ATPase V0 subunit d2 and dendritic cell‑specific transmembrane protein. Mol Med Rep (2014) 0.80

Early origins of chronic obstructive lung diseases across the life course. Eur J Epidemiol (2014) 0.80

Comparison of Bone Mineral Density, T-Scores and Serum Zinc between Diabetic and Non Diabetic Postmenopausal Women with Osteoporosis. J Lab Physicians (2015) 0.79

Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. Am J Clin Nutr (2014) 0.79

Lean mass is the strongest predictor of bone mineral content in type-2 diabetes and normal individuals: an eastern India perspective. J Diabetes Metab Disord (2014) 0.78

Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskelet Disord (2013) 0.77

The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes. Diabetes Care (2014) 0.77

Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study. BMC Musculoskelet Disord (2014) 0.77

Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia. Calcif Tissue Int (2013) 0.77

The association between the serum C-peptide level and bone mineral density. PLoS One (2013) 0.77

Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help. Front Plant Sci (2016) 0.76

Evaluation of Singh Index and Osteoporosis Self-Assessment Tool for Asians as risk assessment tools of hip fracture in patients with type 2 diabetes mellitus. J Orthop Surg Res (2017) 0.75

The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus. Diabetol Metab Syndr (2015) 0.75

Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus. BMC Endocr Disord (2016) 0.75

Diabetes and bone health: latest evidence and clinical implications. Ther Adv Musculoskelet Dis (2017) 0.75

Quantitative imaging methods in osteoporosis. Quant Imaging Med Surg (2016) 0.75

Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag (2017) 0.75

Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone (2013) 0.75

Harnessing Finger Millet to Combat Calcium Deficiency in Humans: Challenges and Prospects. Front Plant Sci (2017) 0.75

Osteoporosis in Otherwise Healthy Patients with Type 2 Diabetes: A Prospective Gender Based Comparative Study. Indian J Endocrinol Metab (2017) 0.75

Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study. Osteoporos Int (2017) 0.75

Imaging of diabetic bone. Endocrine (2017) 0.75

Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol Rev (2017) 0.75

Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study. Osteoporos Int (2016) 0.75

Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study. Wellcome Open Res (2017) 0.75

Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis. Diabetes Metab Syndr Obes (2017) 0.75

Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010. PLoS One (2017) 0.75

Articles cited by this

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37

The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab (2001) 9.53

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50

Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care (1999) 2.91

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ (2009) 2.90

Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70

Relationships between fat and bone. Osteoporos Int (2007) 2.51

Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab (2006) 2.34

Thiazide diuretics and the risk for hip fracture. Ann Intern Med (2003) 2.24

Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int (2005) 2.15

Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab (1998) 2.14

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA (2011) 2.04

Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res (2006) 2.01

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93

Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology (2000) 1.93

Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept (2000) 1.91

Adiponectin and its receptors are expressed in bone-forming cells. Bone (2004) 1.86

FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res (2012) 1.82

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun (2005) 1.80

Bone loss and bone turnover in diabetes. Diabetes (1995) 1.74

Sarcopenia and age-related changes in body composition and functional capacity. J Nutr (1993) 1.74

Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med (2002) 1.71

Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res (2005) 1.70

Leptin inhibits osteoclast generation. J Bone Miner Res (2002) 1.64

Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res (2004) 1.64

High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.64

Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab (2007) 1.63

Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem (2002) 1.49

Thiazide effect on the mineral content of bone. N Engl J Med (1983) 1.48

Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone (2009) 1.35

Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res (2004) 1.33

Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int (2005) 1.27

Regulation of osteoclast function and bone mass by RAGE. J Exp Med (2006) 1.21

Effect of fat on measurement of bone mineral density. Int J Body Compos Res (2009) 1.18

Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit (2009) 1.16

Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2003) 1.16

Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem (2006) 1.14

Bone metabolism and fracture risk in type 2 diabetes mellitus [Review]. Endocr J (2011) 1.09

Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia (1998) 1.08

Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA (1992) 1.07

The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J Bone Miner Res (1989) 1.05

Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia (2006) 1.04

Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. J Diabetes Complications (2008) 1.01

Insulin-like growth factor-I and bone: lessons from mice and men. Pediatr Nephrol (2008) 1.01

Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthop Relat Res (1995) 1.01

Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications (1996) 1.01

Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol (2003) 1.01

Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int (1999) 0.99

Simulated change in body fatness affects Hologic QDR 4500A whole body and central DXA bone measures. J Clin Densitom (2006) 0.99

HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res (2004) 0.98

Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract (2010) 0.97

Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int (2004) 0.96

Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab (1992) 0.95

Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J (2004) 0.95

Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia (2004) 0.93

Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif Tissue Int (2007) 0.93

Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res (2003) 0.93

Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr Diabetes Rev (2005) 0.90

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes (2008) 0.90

Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynaecol Res (1996) 0.89

[Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey]. Orthopade (2005) 0.89

Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus. Ann Saudi Med (2008) 0.88

Diabetes and osteoporosis. Aging Clin Exp Res (2008) 0.87

Bone mass in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest (1995) 0.87

Osteoporosis in type II diabetes. Acta Diabetol Lat (1988) 0.85

Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol (2005) 0.85

Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc (2006) 0.85

Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications (2004) 0.84

Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Medica (Hradec Kralove) (2001) 0.83

Circadian variation of serum leptin in healthy and diabetic men. Chronobiol Int (2001) 0.83

Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest (2010) 0.82

Diabetes and premature menopause: is their co-existence detrimental to the skeleton? Eur J Endocrinol (2005) 0.80

[Negative correlation between BMD and HbA1C in patients with type 2 diabetes]. Clin Calcium (2006) 0.80

Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China. J Bone Miner Metab (2009) 0.80

Type 2 diabetes mellitus and osteopenia: is there an association? Acta Diabetol (2003) 0.79

Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Braz J Med Biol Res (2007) 0.79

Total and regional bone mineral content in patients with non-insulin dependent diabetes mellitus. J Nutr Sci Vitaminol (Tokyo) (1991) 0.79

Evolution, aging, and osteoporosis. Ann N Y Acad Sci (2007) 0.78

Diabetes mellitus and male osteoporosis. Is there a relationship? Saudi Med J (2006) 0.78

Age curves of bone mineral density at the distal radius and calcaneus in Koreans. J Bone Miner Metab (2009) 0.76

[Bone mineral density in postmenopausal elderly women with type 2 diabetes]. Nihon Ronen Igakkai Zasshi (1995) 0.76

Decreased bone mineral density in diabetic patients on hemodialysis. Contrib Nephrol (1991) 0.76

[Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status]. Orv Hetil (2007) 0.76

Articles by these authors

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res (2008) 6.73

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med (2006) 6.04

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Correlation between genetic and geographic structure in Europe. Curr Biol (2008) 5.02

Genomic inflation factors under polygenic inheritance. Eur J Hum Genet (2011) 4.89

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature (2006) 4.80

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA (2012) 4.57

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38

Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet (2009) 4.24

Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98

ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res (2007) 3.96

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell (2012) 3.92

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80

TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res (2009) 3.79

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55

Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet (2012) 3.48

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18

Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15

Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling. J Cell Biol (2009) 3.04

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol (2013) 2.91

The Generation R Study: design and cohort update 2012. Eur J Epidemiol (2012) 2.84

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med (2009) 2.80

FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76

The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73

CryptoDB: a Cryptosporidium bioinformatics resource update. Nucleic Acids Res (2006) 2.68

Evaluation of sublingual and gut mucosal microcirculation in sepsis: a quantitative analysis. Crit Care Med (2009) 2.68

Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis. Hum Mol Genet (2008) 2.66

Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One (2013) 2.65

A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60

Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet (2009) 2.58

Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52

DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell (2008) 2.46

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell (2010) 2.44

An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet (2010) 2.43

RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012) 2.41

Heterogeneous aspirations promote cooperation in the prisoner's dilemma game. PLoS One (2010) 2.41

Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care (2009) 2.41

Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell (2011) 2.37

Impact of agricultural management practices on soil organic carbon: simulation of Australian wheat systems. Glob Chang Biol (2013) 2.37

Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36

GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens Giardia lamblia and Trichomonas vaginalis. Nucleic Acids Res (2008) 2.35

Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34